Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ormandy

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Research|March 23, 2005
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinomaLars A Ormandy, Tina Hillemann, Heiner Wedemeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinomaFirouzeh Korangy, Lars A Ormandy, Jörg S Bleck, et al.
Gastroenterology|May 20, 2008
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cellsBastian Hoechst, Lars A Ormandy, Matthias Ballmaier, et al.
Oncoimmunology|November 22, 2012
Primary sterile necrotic cells fail to cross-prime CD8(+) T cellsJaba Gamrekelashvili, Lars A Ormandy, Markus M Heimesaat, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2010
Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCCTim F Greten, Lars A Ormandy, Annika Fikuart, et al.
World Journal of Gastroenterology|May 24, 2006
Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinomaLars-A Ormandy, Anatol Farber, Tobias Cantz, et al.
BMC Cancer|May 19, 2010
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinomaTim F Greten, Alejandro Forner, Firouzeh Korangy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2012
Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responsesFei Zhao, Bastian Hoechst, Jaba Gamrekelashvili, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Research|March 23, 2005
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinomaLars A Ormandy, Tina Hillemann, Heiner Wedemeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinomaFirouzeh Korangy, Lars A Ormandy, Jörg S Bleck, et al.
Gastroenterology|May 20, 2008
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cellsBastian Hoechst, Lars A Ormandy, Matthias Ballmaier, et al.
Oncoimmunology|November 22, 2012
Primary sterile necrotic cells fail to cross-prime CD8(+) T cellsJaba Gamrekelashvili, Lars A Ormandy, Markus M Heimesaat, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2010
Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCCTim F Greten, Lars A Ormandy, Annika Fikuart, et al.
World Journal of Gastroenterology|May 24, 2006
Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinomaLars-A Ormandy, Anatol Farber, Tobias Cantz, et al.
BMC Cancer|May 19, 2010
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinomaTim F Greten, Alejandro Forner, Firouzeh Korangy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2012
Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responsesFei Zhao, Bastian Hoechst, Jaba Gamrekelashvili, et al.
Pageof 1